KITE
T. Rowe Price Associates’s Kite Pharma, Inc. KITE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,683,954
| Closed | -$483M | – | 2658 |
|
|
2017
Q3 | $483M | Sell |
2,683,954
-2,431,685
| -48% | -$437M | 0.08% | 260 |
|
|
2017
Q2 | $530M | Buy |
5,115,639
+1,907,805
| +59% | +$198M | 0.1% | 239 |
|
|
2017
Q1 | $252M | Buy |
3,207,834
+1,673,340
| +109% | +$131M | 0.05% | 377 |
|
|
2016
Q4 | $68.8M | Buy |
1,534,494
+1,012,926
| +194% | +$45.4M | 0.01% | 699 |
|
|
2016
Q3 | $29.1M | Buy |
521,568
+281,826
| +118% | +$15.7M | 0.01% | 995 |
|
|
2016
Q2 | $12M | Buy |
239,742
+224,752
| +1,499% | +$11.2M | ﹤0.01% | 1253 |
|
|
2016
Q1 | $688K | Buy |
14,990
+3,810
| +34% | +$175K | ﹤0.01% | 1844 |
|
|
2015
Q4 | $689K | Buy |
+11,180
| New | +$689K | ﹤0.01% | 1819 |
|
|
2015
Q3 | – | Sell |
-137,350
| Closed | -$8.37M | – | 2560 |
|
|
2015
Q2 | $8.37M | Buy |
+137,350
| New | +$8.37M | ﹤0.01% | 1388 |
|